Thalidomide-5-NH-CH2-COO(t-Bu) is a thalidomide-derived E3 Ligase Ligand specifically engineered for use in PROTAC and molecular glue development. With a tert-butyl ester modification at the 5-amino position, this compound provides a versatile handle for linker attachment, facilitating the creation of cereblon (CRBN)-recruiting PROTACs. Thalidomide-based ligands are widely used in targeted protein degradation strategies due to their high affinity and selectivity for the CRBN E3 ubiquitin ligase complex. This compound enables researchers to design and synthesize innovative molecules for targeted protein degradation, accelerating drug discovery and development across oncology, immunology, and other therapeutic fields.
Structure of 2412056-28-9
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
Thalidomide-5-NH-CH2-COO(t-Bu) is a strategically engineered derivative of thalidomide, one of the most widely used Cereblon (CRBN) E3 ligase ligands in targeted protein degradation research. By introducing a carbamate linker at the 5-amino position appended with a tert-butyl protected carboxyl group, this molecule exhibits enhanced chemical stability and versatility for the synthesis of PROTACs (Proteolysis Targeting Chimeras) and other heterobifunctional degraders. Its unique structure ensures optimal positioning of the functionalized linker to aid in efficient conjugation during degrader development.
Mechanism
Thalidomide-5-NH-CH2-COO(t-Bu) operates as a high-affinity ligand for the CRBN protein, the substrate receptor subunit in the CUL4A-CRBN E3 ubiquitin ligase complex. When incorporated into PROTACs, this compound recruits the CRBN E3 ligase to the target protein by virtue of its selective binding. The tert-butyl ester serves as a protected acidic handle, facilitating straightforward linker modification and conjugation. Upon binding, the proximity-induced ubiquitination of the target protein is initiated, ultimately leading to its recognition and degradation by the 26S proteasome system.
Applications
Thalidomide-5-NH-CH2-COO(t-Bu) is an invaluable building block in the design of CRBN-recruiting PROTACs and molecular glue degraders for targeted protein degradation. Its stable and modifiable linker enables seamless conjugation with a broad spectrum of protein-targeting ligands, supporting advanced SAR studies and rational PROTAC optimization.
Common applications include:
• Synthesis of CRBN-based PROTAC molecules for degrader screening and development
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.